Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | RORC | P51449 | 3/20 | 0.45 |
| ▸ | NAMPT | P43490 | 2/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.43 |
| ▸ | GABRE | P78334 | 1/20 | 0.43 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.43 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.43 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.43 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.43 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12184770 | 0.86 | L3MBTL1 (0.48) | L3MBTL1NAMPTHDAC1DYRK1ACA12 | |
| SCHEMBL13707768 | 0.83 | L3MBTL1 (0.46) | L3MBTL1NAMPTGLSHDAC1DYRK1A | |
| SCHEMBL1244728 | 0.82 | EPHX2 (0.56) | L3MBTL1RORCNAMPTGLSHDAC1 | |
| SCHEMBL2841433 | 0.82 | GABRP (0.46) | L3MBTL1NAMPTGABRPGABRDGABRA1 | |
| SCHEMBL1244524 | 0.81 | NAMPT (0.46) | L3MBTL1NAMPTP4HTMHDAC1CA12 | |
| SCHEMBL2586887 | 0.81 | L3MBTL1 (0.54) | L3MBTL1NAMPTHDAC1DYRK1ACA1 | |
| SCHEMBL30006337 | 0.81 | L3MBTL1 (0.54) | L3MBTL1NAMPTHDAC1DYRK1ACA1 | |
| SCHEMBL6369161 | 0.81 | L3MBTL1 (0.44) | L3MBTL1NAMPTGLSDYRK1ACA12 | |
| SCHEMBL6376889 | 0.81 | L3MBTL1 (0.44) | L3MBTL1NAMPTGLSDYRK1ACA12 | |
| SCHEMBL30385608 | 0.81 | MEN1 (0.53) | NAMPTHDAC1MAPTTDP1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3447058-B1 | NOVEL BROAD-SPECTRUM BETA-LACTAMASE INHIBITOR | WUHAN VISION PHARMACEUTICAL TECH CO LTD (CN) | 2023-10-11 | — | — | EP | disclosed |
| US-10479805-B2 | Beta-lactamase inhibitor | WUHAN VISION PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2019-11-19 | — | — | US | disclosed |
| US-20190048027-A1 | BETA-LACTAMASE INHIBITOR | WUHAN VISION PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190048027-A1 | BETA-LACTAMASE INHIBITOR | ALPI, MGAM, LCT | L3MBTL1 391/4885RORC 2902/4885NAMPT 949/4885 |
| US-10479805-B2 | Beta-lactamase inhibitor | ALPI, MGAM, LCT | L3MBTL1 391/4885RORC 2902/4885NAMPT 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.